You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

temozolomide resistant

Showing 1 - 25 of 6,153
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Trial in Birmingham (Autologous genetically modified gamma-delta T cells, Allogeneic genetically modified

Not yet recruiting
  • Glioblastoma
  • Autologous genetically modified gamma-delta T cells
  • Allogeneic genetically modified gamma-delta T cells
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 16, 2022

Advanced Solid Tumor, Platinum-Resistant Ovarian Cancer, Platinum-Resistant Urothelial Carcinoma Trial in Darlinghurst, Kogarah,

Terminated
  • Advanced Solid Tumor
  • +3 more
  • Darlinghurst, New South Wales, Australia
  • +1 more
Dec 18, 2022

Brain Tumor Adult Trial in Birmingham (DRI cell therapy)

Recruiting
  • Brain Tumor Adult
  • DRI cell therapy
  • Birmingham, Alabama
    University of Alabama at Birmingham
Feb 1, 2022

Gastrointestinal Stromal Tumors Trial in Seoul (Temozolomide capsule)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Temozolomide capsule
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Dec 14, 2022

Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma Trial in Bethesda, Cleveland (biological,

Not yet recruiting
  • Glioblastoma Multiforme
  • +3 more
  • P140K-MGMT
  • +5 more
  • Bethesda, Maryland
  • +1 more
Jul 4, 2022

Glioblastoma Multiforme Trial in Cleveland (biological, drug, other, procedure, radiation)

Active, not recruiting
  • Glioblastoma Multiforme
  • MGMTP140K-encoding retroviral vector
  • +6 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
May 6, 2022

Colorectal Cancer Trial (Irinotecan, Temozolomide)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 1, 2022

Neuroblastoma (NB) Trial in New York (Irinotecan, temozolomide, Hu3F8)

Active, not recruiting
  • Neuroblastoma (NB)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 19, 2021

Advanced Solid Tumours, Small Cell Lung Cancer Trial in Australia, Korea, Republic of, Taiwan (IMP4297)

Recruiting
  • Advanced Solid Tumours
  • Small Cell Lung Cancer
  • Albury, New South Wales, Australia
  • +12 more
Aug 10, 2021

Glioblastoma Trial (Azeliragon)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Aug 3, 2023

Rectal Cancer Trial in Milan (External-beam radiation, Capecitabine, Temozolomide)

Recruiting
  • Rectal Cancer
  • External-beam radiation
  • +2 more
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Jan 25, 2022

SCLC After Initial Treatment Failure

Not yet recruiting
  • Small-cell Lung Cancer
    • (no location specified)
    Mar 8, 2021

    Glioblastoma, Melanoma Stage IV, Melanoma Recurrent Trial in United Kingdom, United States (ST101)

    Recruiting
    • Glioblastoma
    • +11 more
    • San Francisco, California
    • +11 more
    Jul 13, 2022

    MGMT-Unmethylated Glioblastoma Trial (Etoposide Plus Cisplatin)

    Not yet recruiting
    • MGMT-Unmethylated Glioblastoma
    • Etoposide Plus Cisplatin
    • (no location specified)
    Jan 12, 2023

    Glioblastoma, Malignant Glioma Trial in Canada, Switzerland, United States (drug, radiation, device)

    Completed
    • Glioblastoma
    • Malignant Glioma
    • La Jolla, California
    • +7 more
    Apr 13, 2021

    Ovarian Cancer Trial in Worldwide (NovoTTF-100L(O), Paclitaxel)

    Active, not recruiting
    • Ovarian Cancer
    • Phoenix, Arizona
    • +118 more
    Apr 19, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +15 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Chicago, Illinois
    • +2 more
    Jan 12, 2023

    Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy,

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • +2 more
    • Biopsy
    • +5 more
    • (no location specified)
    Jan 18, 2023

    Newly Diagnosed Glioblastoma Trial in United States (SurVaxM)

    Recruiting
    • Newly Diagnosed Glioblastoma
    • SurVaxM
    • San Francisco, California
    • +9 more
    Aug 23, 2022

    Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3 Trial in United States (other, radiation, drug)

    Active, not recruiting
    • Astrocytoma, IDH-Mutant, Grade 2
    • Astrocytoma, IDH-Mutant, Grade 3
    • Questionnaire Administration
    • +3 more
    • Phoenix, Arizona
    • +24 more
    Dec 7, 2022

    Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)

    Active, not recruiting
    • Anaplastic Astrocytoma
    • +2 more
    • Radiation Therapy
    • +2 more
    • Birmingham, Alabama
    • +162 more
    Dec 30, 2022

    Recurrent Extensive Stage Small Cell Lung Carcinoma, Refractory Extensive Stage Small Cell Lung Carcinoma Trial in United States

    Active, not recruiting
    • Recurrent Extensive Stage Small Cell Lung Carcinoma
    • Refractory Extensive Stage Small Cell Lung Carcinoma
    • Bakersfield, California
    • +5 more
    Jan 5, 2023

    Refractory Solid Tumors Trial in Houston (Eribulin, Irinotecan, Temozolomide)

    Recruiting
    • Refractory Solid Tumors
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 22, 2023

    Glioblastoma, Gliosarcoma Trial in United States (drug, radiation, other)

    Recruiting
    • Glioblastoma
    • Gliosarcoma
    • Little Rock, Arkansas
    • +119 more
    Aug 11, 2022

    Gastrinoma, Glucagonoma, Insulinoma Trial in United States (temozolomide, capecitabine, laboratory biomarker analysis)

    Active, not recruiting
    Has Results
    • Gastrinoma
    • +6 more
    • Anaheim, California
    • +322 more
    Oct 14, 2022